Durvalumab vs Memantine

## Durvalumab vs Memantine: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Memantine**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Memantine**: Non-competitive NMDA receptor antagonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Memantine — 60-80 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Memantine — C12H21N.

**Molecular Weight**: Durvalumab — N/A; Memantine — 179.3080 g/mol.

**Type**: Durvalumab — Antibody; Memantine — Small molecule.